Elevated serum levels of TNF-α, IL-6 and IL-18 in chronic schizophrenic patients

Schizophrenia Research

Volumn 159, Issue 2-3, 2014, Pages 556-557

  Luo, Yayan ^a   He, Hongbo ^a   Zhang, Minling ^a   Huang, Xini ^a   Zhang, Jie ^a   Zhou, Yanling ^a   Liu, Xianguo ^b   Fan, Ni ^a  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CHLORPROMAZINE; INTERLEUKIN 1; INTERLEUKIN 18; INTERLEUKIN 2; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADAPTIVE IMMUNITY; ADOLESCENT; ADULT; AGE; AGED; CHRONIC DISEASE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE DURATION; DRINKING BEHAVIOR; FEMALE; HUMAN; IMMUNOREACTIVITY; INNATE IMMUNITY; LETTER; LYMPHOCYTE ACTIVATION; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; POSITIVE AND NEGATIVE SYNDROME SCALE; SCHIZOPHRENIA; SEX DIFFERENCE; SMOKING; TH1 CELL;

EID: 84922464142     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2014.09.015     Document Type: Letter

References (10)

1. Kinney D.K., Hintz K., Shearer E.M., Barch D.H., Riffin C., Whitley K., Butler R. A unifying hypothesis of schizophrenia: abnormal immune system development may help explain roles of prenatal hazards, post-pubertal onset, stress, genes, climate, infections, and brain dysfunction. Med. Hypotheses 2010, 74:555-563.
2. Meyer U. Developmental neuroinflammation and schizophrenia. Prog. Neuropsychopharmacol. Biol. Psychiatry 2013, 42:20-34.
3. Palladino I., Salani F., Ciaramella A., Rubino I.A., Caltagirone C., Fagioli S., Spalletta G., Bossù P. Elevated levels of circulating IL-18BP and perturbed regulation of IL-18 in schizophrenia. J. Neuroinflammation 2012, 9:206.
4. Potvin S., Stip E., Sepehry A.A., Gendron A., Bah R., Kouassi E. Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review. Biol. Psychiatry 2008, 63:801-808.
5. Reale M., Patruno A., De Lutiis M.A., Pesce M., Felaco M., Di Giannantonio M., Di Nicola M., Grilli A. Dysregulation of chemo-cytokine production in schizophrenic patients versus healthy controls. BMC Neurosci. 2011, 25:12-13.
6. Schwarz M.J., Muller N., Riedel M., Ackenheil M. The Th2-hypothesis of schizophrenia: a strategy to identify a subgroup of schizophrenia caused by immune mechanisms. Med. Hypotheses 2001, 56:483-486.
7. Smith R.S., Maes M. The macrophage-T-lymphocyte theory of schizophrenia: additional evidence. Med. Hypotheses 1995, 45:135-141.
8. Song X.Q., Lv L.X., Li W.Q., Hao Y.H., Zhao J.P. The interaction of nuclear factor-kappa B and cytokines is associated with schizophrenia. Biol. Psychiatry 2009, 65:481-488.
9. Song X., Fan X., Song X., Zhang J., Zhang W., Li X., Gao J., Harrington A., Ziedonis D., Lv L. Elevated levels of adiponectin and other cytokines in drug naïve, first episode schizophrenia patients with normal weight. Schizophr. Res. 2013, 150:269-273.
10. Xiu M.H., Chen D.C., Wang D., Zhang K., Dong A., Tang W., Zhang F., Liu L.J., Liu J.H., Liu H.B., Yang F.D., Kosten T.R., Zhang X.Y. Elevated interleukin-18 serum levels in chronic schizophrenia: association with psychopathology. J. Psychiatr. Res. 2012, 46:1093-1098.